Vidaza and blood creatinine increased Patient Reports February 12, 2012
Vidaza Side Effects Report #4615678-7
Vidaza side effect was reported by a Physician from on Mar 03, 2005. Male patient, 82 years of age, weighting 138.9 lb, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: abdominal discomfort, anaemia, asthenia, atelectasis, bilirubin conjugated increased, blood bilirubin increased, blood creatinine increased, febrile neutropenia, infection
. Vidaza dosage: 75 MG/M2 (127 MG, DAILY), SUBCUTANEOUS. During the same period patient was treated with PROCRIT, NEUPOGEN, ZOLOFT, TARKA, PRINIVIL, ASPIRIN, PLAVIX. Patient was hospitalized. Patient died on 08/31/2004.Vidaza Side Effects Report #4906736-8
Vidaza side effect was reported by a Physician from UNITED STATES on Jan 25, 2006. Male patient, 80 years of age, weighting 180.0 lb, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood creatinine increased, blood potassium increased, confusional state, depressed level of consciousness, dyspnoea, international normalised ratio increased, lethargy. Vidaza dosage: 75 MG/M2, SUBCUTANEOUS. During the same period patient was treated with WARFARIN, DIGOXIN, FUROSEMIDE, MODAFINIL, ESZOPICLONE. Patient was hospitalized. Patient recovered.
Vidaza Side Effects Report #5614727-7
Vidaza side effect was reported by a Physician from UNITED STATES on Jan 17, 2008. Male patient, 56 years of age, weighting 227.1 lb, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: blood creatinine increased, hepatic enzyme increased, pneumocystis jiroveci pneumonia, refusal of treatment by relative, respiratory failure, tachycardia. Vidaza dosage: 230 MG, DAILY. During the same period patient was treated with DACOGEN. Patient was hospitalized. Patient died on 10/20/2007.
Vidaza Side Effects Report #5526552-6
Vidaza side effect was reported by a Pharmacist from UNITED STATES on Nov 21, 2007. Male patient, weighting 227.1 lb, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: blood creatinine increased, hepatic enzyme increased, insomnia, pneumonia
, refusal of treatment by relative, respiratory failure, tachycardia, tuberculosis
. Vidaza dosage: 230MG DAILY IV; 10 CYLES. During the same period patient was treated with DACOGEN. Patient was hospitalized. Patient died on 10/20/2007.Vidaza Side Effects Report #4631524-X
Vidaza side effect was reported by a Physician from on Mar 23, 2005. Male patient, 78 years of age, weighting 145.9 lb, was diagnosed with acute myeloid leukaemia and was treated with Vidaza. After drug was administered, patient experienced the following side effects: anion gap increased, atrial tachycardia, blood bicarbonate decreased, blood creatinine increased, blood ph decreased, blood potassium increased, electrocardiogram st segment depression, haematocrit decreased, heart rate decreased. Vidaza dosage: 75 MG/M2 (135 MG), SUBCUTANEOUS. During the same period patient was treated with ASPIRIN, HYDROCHLOROTHIAZIDE, POTASSIUM CHLORIDE. Patient died on 12/01/2004.
Vidaza Side Effects Report #5762002-2
Vidaza side effect was reported by a Physician from FRANCE on May 20, 2008. Male patient, 50 years of age, was diagnosed with acute myeloid leukaemia and was treated with Vidaza. After drug was administered, patient experienced the following side effects: blood creatinine increased, complications of bone marrow transplant, cytolytic hepatitis, renal failure. Vidaza dosage: 75 MG/M2, DAILY, SUBCUTANEOUS. During the same period patient was treated with ROVAMYCINE, VALACYCLOVIR, CORTICOSTEROIDS, GRANOCYTE, AUGMENTIN, AMOXICILLIN. Patient recovered.
Vidaza and blood creatinine increased 